Tx Archives - Family Medicine News

More aggressive statin tx needed after heart attack in young patients

14.06.2019 Health Problems

(HealthDay)—The majority of young heart attack patients with familial hypercholesterolemia (FH) still have elevated cholesterol levels a year later, according to a study published in the May 21 issue of the Journal of the American College of Cardiology. Avinainder Singh, M.D., from Brigham and Women’s Hospital in Boston, and colleagues used data from the YOUNG-MI registry to assess the prevalence […]

Malpractice damage caps associated with change in CAD testing, Tx

08.06.2018 Health Problems

(HealthDay)—Following adoption of damage caps, physicians alter their approach to coronary artery disease testing and follow-up after initial ischemic evaluations, according to a study published online June 6 in JAMA Cardiology. Steven A. Farmer, M.D., Ph.D., from George Washington University in Washington, D.C., and colleagues examined whether reducing malpractice risk is associated with clinical decisions involving coronary artery disease testing […]

Elevated HbA1c usually leads to prompt Tx start, intensification

31.05.2018 Health Problems

(HealthDay)—Most patients are newly initiated on antidiabetic therapy or have antidiabetic therapy intensified within six months of hemoglobin A1c (HbA1c) elevation, according to a study published online May 24 in Diabetes Care. Lauren G. Gilstrap, M.D., from Harvard Medical School in Boston, and colleagues used data from 2008 to 2015 commercial claims linked with laboratory and pharmacy data to create […]

PSA level three months after radiation tx may predict outcome

25.05.2018 Health Problems

(HealthDay)—Prostate-specific antigen (PSA) levels three months after radiotherapy (RT) are strong markers of prostate cancer outcomes for patients with intermediate- and high-risk disease, according to a study published online May 4 in Cancer. Alex K. Bryant, from University of California at San Diego, and colleagues used Veterans Affairs data to identify 5,783 patients with intermediate-risk or high-risk localized prostate cancer […]

PPD skin test enhances bacillus Calmette-Guerin Tx in bladder CA

17.05.2018 Health Problems

(HealthDay)—For patients with non-muscle invasive bladder cancer, undergoing the purified protein derivative skin test prior to bacillus Calmette-Guérin therapy may have therapeutic impact, according to a study published in the June issue of The Journal of Urology. Naoya Niwa, M.D., from the Keio University School of Medicine in Tokyo, and colleagues treated 498 patients with non-muscle invasive bladder cancer with […]